Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
3.24
-0.05 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
3.25
0.31%
After-hours: Aug 15, 2025, 07:55 PM EDT
Akebia Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 184.91M | 160.18M | 169.88M | 174.5M | 187.22M | 194.75M | 193.73M | 200.65M | 271.03M | 292.6M | 297.03M | 296.82M | 222.97M | 213.58M | 210.67M | 221.9M | 259.13M |
Cost of Revenue | 59.6M | 63.94M | 62.64M | 66.48M | 66.32M | 73.84M | 56.83M | 76.77M | 78.09M | 89.95M | 138.24M | 116.24M | 150.13M | 153.4M | 166.28M | 180.68M | 302.8M |
Gross Profit | 125.31M | 96.24M | 107.24M | 108.01M | 120.9M | 120.91M | 136.9M | 123.88M | 192.94M | 202.66M | 158.79M | 180.58M | 72.84M | 60.18M | 44.39M | 41.22M | -43.67M |
Operating Income | -22.02M | -50.41M | -34.73M | -35.27M | -35.54M | -45.49M | -51.99M | -86.95M | -29.11M | -62.77M | -123.8M | -130.69M | -258.88M | -265.32M | -284.57M | -287.77M | -382.25M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.97M | 1.97M | 1.97M |
Pretax Income | -45.31M | -69.41M | -45.99M | -40.44M | -43.03M | -51.27M | -59.43M | -96.81M | -56.36M | -92.56M | -155.69M | -163.37M | -275.68M | -282.84M | -299.16M | -299.58M | -392.29M |
Net Income | -45.31M | -69.41M | -45.99M | -40.44M | -43.03M | -41.78M | -51.15M | -92.4M | -51.95M | -101.56M | -163.49M | -167.29M | -279.61M | -282.84M | -299.16M | -299.58M | -392.29M |
Selling & General & Admin | 107.61M | 108.02M | 106.63M | 102.83M | 102.19M | 101.26M | 104.88M | 113.83M | 120.49M | 140.28M | 155.18M | 170.75M | 179.59M | 176.6M | 172.11M | 165.76M | 159.74M |
Research & Development | 37.27M | 36.89M | 34.57M | 39.42M | 52.37M | 62.69M | 85.12M | 99.14M | 104.97M | 129.11M | 126.77M | 139.89M | 151.07M | 147.85M | 155.87M | 162.26M | 177.87M |
Other Expenses | 1.71M | 1.8M | 825K | 13K | -1.6M | -1.13M | -2.33M | -2.29M | -223K | -791K | -4.11M | -3.69M | -4.1M | -3.94M | -1.01M | -1.03M | -650K |
Operating Expenses | 146.63M | 146.65M | 141.98M | 143.11M | 156.36M | 166.32M | 193.96M | 216.07M | 227.62M | 270.99M | 283M | 311.68M | 331.71M | 325.5M | 328.96M | 329M | 338.58M |
Interest Expense | 7.92M | 18.18M | 12.73M | 7.47M | 6.97M | 6.03M | 6.25M | 8.79M | 12.19M | 15.69M | 19.13M | 20.27M | 20.19M | 19.93M | 17.17M | 14.36M | 11.7M |
Selling & Marketing Expenses | n/a | n/a | 25.44M | 48.15M | 75.18M | 100.4M | 81.67M | 58.96M | 31.92M | 6.7M | 8.2M | 8.2M | 8.2M | 8.2M | 5M | 5M | 5M |
Cost & Expenses | 206.23M | 210.59M | 204.61M | 209.59M | 222.69M | 240.16M | 245.65M | 287.69M | 300.55M | 355.79M | 421.24M | 427.92M | 481.85M | 478.9M | 495.24M | 509.68M | 641.39M |
Income Tax Expense | n/a | n/a | -1K | -1K | 93K | -9.39M | -8.18M | -4.31M | 221K | 13.63M | 12.43M | 8.55M | 3.93M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 235.5M | 218.7M | 210.35M | 209.71M | 204.96M | 189.9M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 183.6M | 179.6M | 174.65M | 173.78M | 161.33M | 153.82M |
Shares Outstanding (Diluted) | 241.6M | 218.7M | 210.35M | 209.71M | 204.96M | 190.5M | 188.31M | 186.82M | 184.77M | 183.99M | 183.88M | 190.38M | 179.6M | 175.61M | 173.78M | 161.33M | 153.82M |
EPS (Basic) | -0.22 | -0.33 | -0.22 | -0.2 | -0.22 | -0.22 | -0.27 | -0.5 | -0.28 | -0.56 | -0.91 | -0.95 | -1.62 | -1.7 | -1.9 | -1.98 | -2.75 |
EPS (Diluted) | -0.22 | -0.33 | -0.22 | -0.2 | -0.22 | -0.22 | -0.27 | -0.5 | -0.29 | -0.57 | -0.92 | -0.96 | -1.62 | -1.7 | -1.9 | -1.98 | -2.75 |
EBITDA | 5.91M | -13.72M | 5.22M | 5.55M | 2.08M | -7.72M | -21.16M | -58.21M | -14.38M | -46.97M | -102.45M | -107.16M | -219.52M | -226.78M | -247.17M | -252.81M | -347.59M |
EBIT | -35.74M | -51.23M | -33.27M | -32.97M | -36.06M | -45.89M | -40.15M | -77.21M | -33.37M | -65.41M | -141.2M | -145.51M | -257.9M | -265.32M | -281.99M | -285.22M | -380.59M |
Depreciation & Amortization | 28.13M | 37.5M | 37.56M | 37.6M | 37.22M | 36.67M | 36.09M | 35.49M | 35.47M | 35.51M | 35.71M | 35.94M | 35.97M | 36.13M | 34.83M | 32.41M | 32.99M |